( S ) Few studies of medical therapies for endometriosis report outcomes that are relevant to patients , and many women gain only limited or intermittent benefit from treatment
OBJECTIVE To assess patient response rates to medical therapies used to treat endometriosis-associated pain .
Pain of endometriosis: effects of nafarelin and danazol therapy.
OBJECTIVE To compare the efficacy of nafarelin acetate with danazol in the treatment of dysmenorrhea , dyspareunia , and pelvic pain associated with endometriosis . DESIGN Prospect i ve , r and omized double-blind controlled study . PATIENTS , SETTING , TREATMENTS : Two hundred thirteen patients aged 18 to 48 with laparoscopically confirmed pelvic endometriosis and dysmenorrhea , dyspareunia or pelvic pain were r and omly assigned to 6 months of treatment with either nafarelin acetate 800 micrograms per day or 400 micrograms per day , or danazol 800 micrograms per day . MAIN OUTCOME MEASURES The percentage of patients with dysmenorrhea , dyspareunia or pelvic pain before treatment who still had these symptoms after 6 months of treatment and 6 months following completion of treatment . RESULTS [ table : see text ] CONCLUSIONS Nafarelin acetate and danazol both provided significant relief of dysmenorrhea , dyspareunia , and pelvic pain during treatment and for 6 months following treatment in women with endometriosis
( S ) Few studies of medical therapies for endometriosis report outcomes that are relevant to patients , and many women gain only limited or intermittent benefit from treatment
OBJECTIVE To assess patient response rates to medical therapies used to treat endometriosis-associated pain .